Identification of inositol polyphosphate 4-phosphatase type II as a novel tumor resistance biomarker in human laryngeal cancer HEp-2 cells

References

• Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001; 94:153 - 6; http://dx.doi.org/10.1002/ijc.1440; PMID: 11668491
   PubMed Web of Science ®Google Scholar
• Lefebvre JL. Laryngeal preservation in head and neck cancer: multidisciplinary approach. Lancet Oncol 2006; 7:747 - 55; http://dx.doi.org/10.1016/S1470-2045(06)70860-9; PMID: 16945770
   PubMed Web of Science ®Google Scholar
• Nix PA, Greenman J, Cawkwell L, Stafford N. Radioresistant laryngeal cancer: beyond the TNM stage. Clin Otolaryngol Allied Sci 2004; 29:105 - 14; http://dx.doi.org/10.1046/j.1365-2273.2003.00796.x; PMID: 15113291
   PubMed Web of Science ®Google Scholar
• Kim JJ, Tannock IF. Repopulation of cancer cells during therapy: an important cause of treatment failure. Nat Rev Cancer 2005; 5:516 - 25; http://dx.doi.org/10.1038/nrc1650; PMID: 15965493
   PubMed Web of Science ®Google Scholar
• Bussink J, van der Kogel AJ, Kaanders JH. Activation of the PI3-K/AKT pathway and implications for radioresistance mechanisms in head and neck cancer. Lancet Oncol 2008; 9:288 - 96; http://dx.doi.org/10.1016/S1470-2045(08)70073-1; PMID: 18308254
   PubMed Web of Science ®Google Scholar
• Haffty BG, Glazer PM. Molecular markers in clinical radiation oncology. Oncogene 2003; 22:5915 - 25; http://dx.doi.org/10.1038/sj.onc.1206704; PMID: 12947398
   PubMed Web of Science ®Google Scholar
• Kumar B, Cordell KG, D’Silva N, Prince ME, Adams ME, Fisher SG, et al. Expression of p53 and Bcl-xL as predictive markers for larynx preservation in advanced laryngeal cancer. Arch Otolaryngol Head Neck Surg 2008; 134:363 - 9; http://dx.doi.org/10.1001/archotol.134.4.363; PMID: 18427001
   PubMed Web of Science ®Google Scholar
• Wang T, Tamae D, LeBon T, Shively JE, Yen Y, Li JJ. The role of peroxiredoxin II in radiation-resistant MCF-7 breast cancer cells. Cancer Res 2005; 65:10338 - 46; http://dx.doi.org/10.1158/0008-5472.CAN-04-4614; PMID: 16288023
   PubMed Web of Science ®Google Scholar
• Guo G, Yan-Sanders Y, Lyn-Cook BD, Wang T, Tamae D, Ogi J, et al. Manganese superoxide dismutase-mediated gene expression in radiation-induced adaptive responses. Mol Cell Biol 2003; 23:2362 - 78; http://dx.doi.org/10.1128/MCB.23.7.2362-2378.2003; PMID: 12640121
   PubMed Web of Science ®Google Scholar
• Hill BT, Deuchars K, Hosking LK, Ling V, Whelan RD. Overexpression of P-glycoprotein in mammalian tumor cell lines after fractionated X irradiation in vitro. J Natl Cancer Inst 1990; 82:607 - 12; http://dx.doi.org/10.1093/jnci/82.7.607; PMID: 1968980
   PubMed Web of Science ®Google Scholar
• Henness S, Davey MW, Harvie RM, Davey RA. Fractionated irradiation of H69 small-cell lung cancer cells causes stable radiation and drug resistance with increased MRP1, MRP2, and topoisomerase IIalpha expression. Int J Radiat Oncol Biol Phys 2002; 54:895 - 902; http://dx.doi.org/10.1016/S0360-3016(02)03037-7; PMID: 12377343
   PubMed Web of Science ®Google Scholar
• Ryu JS, Um JH, Kang CD, Bae JH, Kim DU, Lee YJ, et al. Fractionated irradiation leads to restoration of drug sensitivity in MDR cells that correlates with down-regulation of P-gp and DNA-dependent protein kinase activity. Radiat Res 2004; 162:527 - 35; http://dx.doi.org/10.1667/RR3260; PMID: 15624307
   PubMed Web of Science ®Google Scholar
• Bottke D, Koychev D, Busse A, Heufelder K, Wiegel T, Thiel E, et al. Fractionated irradiation can induce functionally relevant multidrug resistance gene and protein expression in human tumor cell lines. Radiat Res 2008; 170:41 - 8; http://dx.doi.org/10.1667/RR0986.1; PMID: 18582150
   PubMed Web of Science ®Google Scholar
• Seve M, Chimienti F, Devergnas S, Favier A. In silico identification and expression of SLC30 family genes: an expressed sequence tag data mining strategy for the characterization of zinc transporters’ tissue expression. BMC Genomics 2004; 5:32; http://dx.doi.org/10.1186/1471-2164-5-32; PMID: 15154973
   PubMed Web of Science ®Google Scholar
• Oh J, Lee J, Woo JM, Choi E, Park I, Han C, et al. Systematic identification and integrative analysis of novel genes expressed specifically or predominantly in mouse epididymis. BMC Genomics 2006; 7:314; http://dx.doi.org/10.1186/1471-2164-7-314; PMID: 17166261
   PubMed Web of Science ®Google Scholar
• Kim JS, Ryoo ZY, Chun JS. Cytokine-like 1 (Cytl1) regulates the chondrogenesis of mesenchymal cells. J Biol Chem 2007; 282:29359 - 67; http://dx.doi.org/10.1074/jbc.M700965200; PMID: 17644814
   PubMed Web of Science ®Google Scholar
• Kim JS, Chang JW, Yun HS, Yang KM, Hong EH, Kim DH, et al. Chloride intracellular channel 1 identified using proteomic analysis plays an important role in the radiosensitivity of HEp-2 cells via reactive oxygen species production. Proteomics 2010; 10:2589 - 604; http://dx.doi.org/10.1002/pmic.200900523; PMID: 20461716
   PubMed Web of Science ®Google Scholar
• Norris FA, Auethavekiat V, Majerus PW. The isolation and characterization of cDNA encoding human and rat brain inositol polyphosphate 4-phosphatase. J Biol Chem 1995; 270:16128 - 33; http://dx.doi.org/10.1074/jbc.270.27.16128; PMID: 7608176
   PubMed Web of Science ®Google Scholar
• Norris FA, Atkins RC, Majerus PW. The cDNA cloning and characterization of inositol polyphosphate 4-phosphatase type II. Evidence for conserved alternative splicing in the 4-phosphatase family. J Biol Chem 1997; 272:23859 - 64; http://dx.doi.org/10.1074/jbc.272.38.23859; PMID: 9295334
   PubMed Web of Science ®Google Scholar
• Gewinner C, Wang ZC, Richardson A, Teruya-Feldstein J, Etemadmoghadam D, Bowtell D, et al. Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3K signaling. Cancer Cell 2009; 16:115 - 25; http://dx.doi.org/10.1016/j.ccr.2009.06.006; PMID: 19647222
   PubMed Web of Science ®Google Scholar
• Di Paolo G, De Camilli P. Phosphoinositides in cell regulation and membrane dynamics. Nature 2006; 443:651 - 7; http://dx.doi.org/10.1038/nature05185; PMID: 17035995
   PubMed Web of Science ®Google Scholar
• Kok K, Geering B, Vanhaesebroeck B. Regulation of phosphoinositide 3-kinase expression in health and disease. Trends Biochem Sci 2009; 34:115 - 27; http://dx.doi.org/10.1016/j.tibs.2009.01.003; PMID: 19299143
   PubMed Web of Science ®Google Scholar
• Wymann MP, Schneiter R. Lipid signalling in disease. Nat Rev Mol Cell Biol 2008; 9:162 - 76; http://dx.doi.org/10.1038/nrm2335; PMID: 18216772
   PubMed Web of Science ®Google Scholar
• Barnache S, Le Scolan E, Kosmider O, Denis N, Moreau-Gachelin F. Phosphatidylinositol 4-phosphatase type II is an erythropoietin-responsive gene. Oncogene 2006; 25:1420 - 3; http://dx.doi.org/10.1038/sj.onc.1209187; PMID: 16247441
   PubMed Web of Science ®Google Scholar
• Duan S, Bleibel WK, Huang RS, Shukla SJ, Wu X, Badner JA, et al. Mapping genes that contribute to daunorubicin-induced cytotoxicity. Cancer Res 2007; 67:5425 - 33; http://dx.doi.org/10.1158/0008-5472.CAN-06-4431; PMID: 17545624
   PubMed Web of Science ®Google Scholar
• Jung JJ, Jeung HC, Chung HC, Lee JO, Kim TS, Kim YT, et al. In vitro pharmacogenomic database and chemosensitivity predictive genes in gastric cancer. Genomics 2009; 93:52 - 61; http://dx.doi.org/10.1016/j.ygeno.2008.08.002; PMID: 18804159
   PubMed Web of Science ®Google Scholar
• Dent P, Yacoub A, Fisher PB, Hagan MP, Grant S. MAPK pathways in radiation responses. Oncogene 2003; 22:5885 - 96; http://dx.doi.org/10.1038/sj.onc.1206701; PMID: 12947395
   PubMed Web of Science ®Google Scholar
• Das AK, Sato M, Story MD, Peyton M, Graves R, Redpath S, et al. Non-small-cell lung cancers with kinase domain mutations in the epidermal growth factor receptor are sensitive to ionizing radiation. Cancer Res 2006; 66:9601 - 8; http://dx.doi.org/10.1158/0008-5472.CAN-06-2627; PMID: 17018617
   PubMed Web of Science ®Google Scholar
• Rho JK, Choi YJ, Ryoo BY, Na II, Yang SH, Kim CH, et al. p53 enhances gefitinib-induced growth inhibition and apoptosis by regulation of Fas in non-small cell lung cancer. Cancer Res 2007; 67:1163 - 9; http://dx.doi.org/10.1158/0008-5472.CAN-06-2037; PMID: 17283151
   PubMed Web of Science ®Google Scholar
• Huang WC, Hung MC. Induction of Akt activity by chemotherapy confers acquired resistance. J Formos Med Assoc 2009; 108:180 - 94; http://dx.doi.org/10.1016/S0929-6646(09)60051-6; PMID: 19293033
   PubMed Web of Science ®Google Scholar
• Vivanco I, Sawyers CL. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2002; 2:489 - 501; http://dx.doi.org/10.1038/nrc839; PMID: 12094235
   PubMed Web of Science ®Google Scholar
• Ugi S, Imamura T, Maegawa H, Egawa K, Yoshizaki T, Shi K, et al. Protein phosphatase 2A negatively regulates insulin’s metabolic signaling pathway by inhibiting Akt (protein kinase B) activity in 3T3-L1 adipocytes. Mol Cell Biol 2004; 24:8778 - 89; http://dx.doi.org/10.1128/MCB.24.19.8778-8789.2004; PMID: 15367694
   PubMed Web of Science ®Google Scholar
• Trotman LC, Alimonti A, Scaglioni PP, Koutcher JA, Cordon-Cardo C, Pandolfi PP. Identification of a tumour suppressor network opposing nuclear Akt function. Nature 2006; 441:523 - 7; http://dx.doi.org/10.1038/nature04809; PMID: 16680151
   PubMed Web of Science ®Google Scholar
• Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2002; 2:48 - 58; http://dx.doi.org/10.1038/nrc706; PMID: 11902585
   PubMed Web of Science ®Google Scholar
• Evans A, Bates V, Troy H, Hewitt S, Holbeck S, Chung YL, et al. Glut-1 as a therapeutic target: increased chemoresistance and HIF-1-independent link with cell turnover is revealed through COMPARE analysis and metabolomic studies. Cancer Chemother Pharmacol 2008; 61:377 - 93; http://dx.doi.org/10.1007/s00280-007-0480-1; PMID: 17520257
   PubMed Web of Science ®Google Scholar
• Vordermark D, Brown JM. Endogenous markers of tumor hypoxia predictors of clinical radiation resistance?. Strahlenther Onkol 2003; 179:801 - 11; http://dx.doi.org/10.1007/s00066-003-1150-9; PMID: 14652668
   PubMed Web of Science ®Google Scholar
• Pan JS, Cai JY, Xie CX, Zhou F, Zhang ZP, Dong J, et al. Interacting with HBsAg compromises resistance of jumping translocation breakpoint protein to ultraviolet radiation-induced apoptosis in 293FT cells. Cancer Lett 2009; 285:151 - 6; http://dx.doi.org/10.1016/j.canlet.2009.05.009; PMID: 19487072
   PubMed Web of Science ®Google Scholar
• Jung EU, Yoon JH, Lee YJ, Lee JH, Kim BH, Yu SJ, et al. Hypoxia and retinoic acid-inducible NDRG1 expression is responsible for doxorubicin and retinoic acid resistance in hepatocellular carcinoma cells. Cancer Lett 2010; 298:9 - 15; http://dx.doi.org/10.1016/j.canlet.2010.05.020; PMID: 20573444
   PubMed Web of Science ®Google Scholar
• Sasaki J, Kofuji S, Itoh R, Momiyama T, Takayama K, Murakami H, et al. The PtdIns(3,4)P(2) phosphatase INPP4A is a suppressor of excitotoxic neuronal death. Nature 2010; 465:497 - 501; http://dx.doi.org/10.1038/nature09023; PMID: 20463662
   PubMed Web of Science ®Google Scholar
• Nystuen A, Legare ME, Shultz LD, Frankel WN. A null mutation in inositol polyphosphate 4-phosphatase type I causes selective neuronal loss in weeble mutant mice. Neuron 2001; 32:203 - 12; http://dx.doi.org/10.1016/S0896-6273(01)00468-8; PMID: 11683991
   PubMed Web of Science ®Google Scholar
• Salmena L, Carracedo A, Pandolfi PP. Tenets of PTEN tumor suppression. Cell 2008; 133:403 - 14; http://dx.doi.org/10.1016/j.cell.2008.04.013; PMID: 18455982
   PubMed Web of Science ®Google Scholar
• Agoulnik IU, Hodgson MC, Bowden WA, Ittmann MM. INPP4B: the new kid on the PI3K block. Oncotarget 2011; 2:321 - 8; PMID: 21487159
   PubMed Web of Science ®Google Scholar
• Kisseleva MV, Cao L, Majerus PW. Phosphoinositide-specific inositol polyphosphate 5-phosphatase IV inhibits Akt/protein kinase B phosphorylation and leads to apoptotic cell death. J Biol Chem 2002; 277:6266 - 72; http://dx.doi.org/10.1074/jbc.M105969200; PMID: 11706019
   PubMed Web of Science ®Google Scholar
• Kim JS, Park ZY, Yoo YJ, Yu SS, Chun JS. p38 kinase mediates nitric oxide-induced apoptosis of chondrocytes through the inhibition of protein kinase C zeta by blocking autophosphorylation. Cell Death Differ 2005; 12:201 - 12; http://dx.doi.org/10.1038/sj.cdd.4401511; PMID: 15665819
   PubMed Web of Science ®Google Scholar